DUBLIN, IRELAND--(Marketwire - December 07, 2007) - Trinity Biotech plc (NASDAQ: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will host a conference call today, (Friday 7th December) to discuss today's press release regarding Group Restructuring. The call will be accompanied by a webcast presentation. The link for this presentation is provided below.
